Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life [0.03%]
疾病负担：玫瑰糠疹对患者生活质量的心理社会影响
Tu T Huynh
Tu T Huynh
Background: Rosacea is a chronic skin disorder that adversely affects patients' quality of life. Current studies focus on the therapies that treat the clinical signs and symptoms of rosacea, but the impact of this disease...
Perspectives of quality care in cancer treatment: a review of the literature [0.03%]
癌症治疗中质量护理的观点：文献综述
Lisa M Hess,Gerhardt Pohl
Lisa M Hess
Background: Approximately 1.7 million Americans are diagnosed with cancer annually. There is an increasing demand for high-quality cancer care; however, what constitutes quality care is not well defined. There remains a g...
Real-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases [0.03%]
美国两大行政理赔数据库中转移性去势抵抗性前列腺癌患者皮质类固醇实际使用情况分析
Marie-Hélène Lafeuille,Jonathan Gravel,Amanda Grittner et al.
Marie-Hélène Lafeuille et al.
Background: Prostate cancer is the most common noncutaneous malignancy in men in the United States. Patients with metastatic castration-resistant prostate cancer (mCRPC) may be treated with secondary hormonal therapy or w...
Kip Piper,F Randy Vogenberg
Kip Piper
David B Nash
David B Nash
Review of US Comparative Economic Evidence for Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line VEGF Inhibitor Therapy [0.03%]
美国关于一线VEGF抑制剂治疗失败后转移性肾细胞癌治疗的比较经济证据回顾
Michael K Wong,Xufang Wang,Maruit J Chulikavit et al.
Michael K Wong et al.
Background: In 2006, the economic burden of metastatic renal cell carcinoma (mRCC) was estimated to be up to $1.6 billion worldwide and has since grown annually. With the continuing increase of the economic burden of this...
Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers [0.03%]
从患者报告的结局看肿瘤治疗现状：支付方面临的机遇与挑战
Erin Zagadailov,Michael Fine,Alan Shields
Erin Zagadailov
Background: A patient-reported outcome (PRO) is a subjective report that comes from a patient without interpretation by a clinician. Because of the increasingly significant role of PROs in the development and evaluation o...
Rapid expansion of new oncology care delivery payment models: results from a payer survey [0.03%]
快速扩张的新肿瘤护理交付付款模式：来自保险人调查的结果
Rhonda Greenapple
Rhonda Greenapple
Background: Oncology practices are seeking to adapt to new care delivery models, including accountable care organizations (ACOs), patient-centered medical homes (PCMHs) in oncology, and oncology pathways, as well as new p...
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report [0.03%]
癌症护理中的价值定义：AVBCC 2013指导委员会报告
AVBCC Steering Committee: Co-Chairs;Burt Zweigenhaft,Linda Bosserman,James T Kenney Jr et al.
AVBCC Steering Committee: Co-Chairs;Burt Zweigenhaft et al.
The AVBCC Annual Meeting experiences exponential growth in attendance and participation as oncologists, payers, employers, managed care executives, patient advocates, and drug manufacturers convened in Hollywood, FL, on May 2-5, 2013, for t...
Michael Kolodziej
Michael Kolodziej